0001802630-20-000004.txt : 20200515 0001802630-20-000004.hdr.sgml : 20200515 20200515121557 ACCESSION NUMBER: 0001802630-20-000004 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 EFFECTIVENESS DATE: 20200515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Soleus Capital Management, L.P. CENTRAL INDEX KEY: 0001802630 IRS NUMBER: 384052641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20043 FILM NUMBER: 20882587 BUSINESS ADDRESS: STREET 1: 104 FIELD POINT ROAD STREET 2: FLOOR 2 CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-542-5527 MAIL ADDRESS: STREET 1: 104 FIELD POINT ROAD STREET 2: FLOOR 2 CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001802630 XXXXXXXX 03-31-2020 03-31-2020 Soleus Capital Management, L.P.
104 FIELD POINT ROAD FLOOR 2 GREENWICH CT 06830
13F HOLDINGS REPORT 028-20043 N
Steven J. Musumeci Chief Operating Officer, Soleus Capital Management, L.P. (475) 208-3111 /s/ Steven J. Musumeci Greenwich CT 05-15-2020 0 48 85937 false
INFORMATION TABLE 2 Soleus_13F_03312020.xml ABBVIE INCCOM00287Y109201926500SHSOLE2650000ADURO BIOTECH INCCOM00739L10122281200SHSOLE8120000ADVERUM BIOTECHNOLOGIES INCCOM00773U1083067313900SHSOLE31390000AEGLEA BIOTHERAPEUTICS INCCOM00773J1032500536497SHSOLE53649700ALEXION PHARMACEUTICALS INCCOM015351109429247800SHSOLE4780000ALLERGAN PLCSHSG0177J108258614600SHSOLE1460000AMARIN CORP PLCSPONS ADR NEW02311120636090000SHSOLE9000000AMICUS THERAPEUTICS INCCOM03152W10966572000SHSOLE7200000ANTARES PHARMA INCCOM0366421062039864100SHSOLE86410000AXOGEN INCCOM05463X10678175050SHSOLE7505000AXONICS MODULATION TECHNOLOGCOM05465P101160163000SHSOLE6300000AYTU BIOSCIENCE INCCOM PAR054754700209139600SHSOLE13960000BIOGEN INCCOM09062X1039493000SHSOLE300000CONSTELLATION PHARMCETICLS ICOM21037310656317900SHSOLE1790000CRISPR THERAPEUTICS AGNAMEN AKTH1718210869616400SHSOLE1640000CYTOSORBENTS CORPCOM NEW23283X20653869600SHSOLE6960000DEXCOM INCCOM252131107362213450SHSOLE1345000EIGER BIOPHARMACEUTICALS INCCOM28249U1052755405207SHSOLE40520700ENANTA PHARMACEUTICALS INCCOM29251M10654510600SHSOLE1060000ESSA PHARMA INCCOM NEW29668H70883222080421SHSOLE208042100ESTABLISHMENT LABS HLDGS INCCOMG3124910891463254SHSOLE6325400GRIFOLS S ASP ADR REP B NVT3984384087795387035SHSOLE38703500HARPOON THERAPEUTICS INCCOM41358P1065453470926SHSOLE47092600INSMED INCNOTE 1.750% 1/1457669AA7150180000PRNSOLE18000000IRADIMED CORPCOM46266A1095013234810SHSOLE23481000ITAMAR MED LTDSPONSORED ADS4654371011353114865SHSOLE11486500IVERIC BIO INCCOM46583P10255291607153SHSOLE160715300KADMON HLDGS INCCOM48283N1061077257141SHSOLE25714100LIVONGO HEALTH INCCOM53918310351618100SHSOLE1810000MILLENDO THERAPEUTICS INCCOM60040X103778147406SHSOLE14740600MISONIX INCCOM6048711032245238333SHSOLE23833300NOVOCURE LTDORD SHSG6674U1083775597SHSOLE559700PACIRA BIOSCIENCESCOM6951271002357000SHSOLE700000PTC THERAPEUTICS INCCOM69366J20072716300SHSOLE1630000RAFAEL HLDGS INCCOM CL B75062E106114289131SHSOLE8913100RELMADA THERAPEUTICS INCCOM75955J40237511000SHSOLE1100000REVANCE THERAPEUTICS INCCOM76133010917611869SHSOLE1186900SHOCKWAVE MED INCCOM82489T10440412185SHSOLE1218500STAAR SURGICAL COCOM PAR $0.018523123052527798SHSOLE779800SYNDAX PHARMACEUTICALS INCCOM87164F10523020980SHSOLE2098000TCR2 THERAPEUTICS INCCOM87808K10623730624SHSOLE3062400UNITEDHEALTH GROUP INCCOM91324P10219707900SHSOLE790000VANDA PHARMACEUTICALS INCCOM92165910819719000SHSOLE1900000VERICEL CORPCOM92346J1083231352332SHSOLE35233200XENON PHARMACEUTICALS INCCOM98420N10515013228SHSOLE1322800ZAFGEN INCCOM98885E10310381348399SHSOLE134839900ZYMEWORKS INCCOM98985W102218261528SHSOLE6152800ZYNEX INCCOM98986M1033859348564SHSOLE34856400